This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Stage IA Skin Melanoma, Stage IB Skin Melanoma, Stage IIA Skin Melanoma, Stage IIB Skin Melanoma, Stage IIC Skin Melanoma, Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma or Stage IV Skin Melanoma
and you are
over 12
years old
The phase for this study is not defined.
Show me locations

The purpose

This pilot clinical trial studies recombinant interferon alfa-2b in treating patients with melanoma. Recombinant interferon alfa-2b may interfere with the growth of tumor cells and slow the growth of melanoma

Provided treatments

  • Biological: recombinant interferon alfa-2b
  • Other: laboratory biomarker analysis

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01460875. The sponsor of the trial is William Carson and it is looking for 34 volunteers for the current phase.
Official trial title:
Pilot Study of IFN-alpha-2b Dose Reduction With Dose Optimization